Peptide-drug conjugates

MA40030AUndetermined Publication Date: 2015-12-10JIARUI BIOPHARMACEUTICALS LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA40030
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2014-06-03
Filing Date
2015-06-01
Publication Date
2015-12-10
Patent Text Reader

Abstract

Peptide-drug conjugates comprising p-aminobenzyl carbamoyl or p-aminobenzolyl carbonate self-immolating linkers are disclosed. The peptide-drug conjugates comprise a peptide moiety that can be cleaved by cellular proteases, bound to the self-immolating linker, which linker is bound to a cytotoxic drug moiety. Upon cleavage of the peptide moiety, the linker self- immolates, releasing the cytotoxic drug in active form. Dimeric structures of the peptide drug conjugates comprising two molecules of cytotoxic drug per conjugate are also disclosed.
Need to check novelty before this filing date? Find Prior Art